TW333536B - 14-17-C2-bridged steroids - Google Patents

14-17-C2-bridged steroids

Info

Publication number
TW333536B
TW333536B TW085100899A TW85100899A TW333536B TW 333536 B TW333536 B TW 333536B TW 085100899 A TW085100899 A TW 085100899A TW 85100899 A TW85100899 A TW 85100899A TW 333536 B TW333536 B TW 333536B
Authority
TW
Taiwan
Prior art keywords
stands
hydrogen atom
alkyl radical
stand
hydrogen
Prior art date
Application number
TW085100899A
Other languages
English (en)
Inventor
Schollkope Klaus
Halfbrodt Wolfgang
Kuhnke Joachim
Schwede Wolfgang
Fritzemeier Karl-Heinrich
Krattenmacher Rolf
Muhn Hans-Peter
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of TW333536B publication Critical patent/TW333536B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW085100899A 1994-12-23 1996-01-25 14-17-C2-bridged steroids TW333536B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4447401A DE4447401A1 (de) 1994-12-23 1994-12-23 14,17-C¶2¶-überbrückte Steroide

Publications (1)

Publication Number Publication Date
TW333536B true TW333536B (en) 1998-06-11

Family

ID=6537601

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085100899A TW333536B (en) 1994-12-23 1996-01-25 14-17-C2-bridged steroids

Country Status (33)

Country Link
US (3) US5827842A (zh)
EP (1) EP0799238B1 (zh)
JP (1) JPH10511379A (zh)
KR (1) KR100400621B1 (zh)
CN (1) CN1109689C (zh)
AR (1) AR002263A1 (zh)
AT (1) ATE193300T1 (zh)
AU (1) AU692346B2 (zh)
BG (1) BG63274B1 (zh)
CA (1) CA2208605C (zh)
CZ (1) CZ292696B6 (zh)
DE (2) DE4447401A1 (zh)
DK (1) DK0799238T3 (zh)
EE (1) EE03356B1 (zh)
ES (1) ES2151612T3 (zh)
FI (1) FI972624A (zh)
GR (1) GR3034261T3 (zh)
HU (1) HUP0600457A2 (zh)
IL (1) IL116504A (zh)
LT (1) LT4295B (zh)
LV (1) LV11954B (zh)
NO (1) NO310198B1 (zh)
NZ (1) NZ298770A (zh)
PL (1) PL182642B1 (zh)
PT (1) PT799238E (zh)
RO (1) RO119366B1 (zh)
RU (1) RU2169153C2 (zh)
SI (1) SI9520137A (zh)
SK (1) SK282281B6 (zh)
TW (1) TW333536B (zh)
UA (1) UA45382C2 (zh)
WO (1) WO1996020209A2 (zh)
ZA (1) ZA9510923B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503919B1 (ko) * 1996-09-03 2005-07-27 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 비타민 디 및 스테로이드 유도체들의 합성에 사용되는 중간체들의 제조방법
DE19848305C1 (de) * 1998-10-14 2000-05-25 Schering Ag Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628189A1 (de) 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
US6147065A (en) 2000-11-14
DE59508403D1 (de) 2000-06-29
EP0799238A2 (de) 1997-10-08
BG63274B1 (bg) 2001-08-31
AU4433896A (en) 1996-07-19
LT4295B (lt) 1998-02-25
UA45382C2 (uk) 2002-04-15
CA2208605C (en) 2008-07-15
CA2208605A1 (en) 1996-07-04
ATE193300T1 (de) 2000-06-15
DE4447401A1 (de) 1996-07-04
RO119366B1 (ro) 2004-08-30
ZA9510923B (en) 1996-07-04
MX9704774A (es) 1997-10-31
JPH10511379A (ja) 1998-11-04
LV11954A (lv) 1998-01-20
FI972624A0 (fi) 1997-06-18
LT97106A (en) 1997-10-27
SK78897A3 (en) 1997-12-10
KR100400621B1 (ko) 2004-02-05
US5973172A (en) 1999-10-26
BG101554A (en) 1998-09-30
NZ298770A (en) 1999-10-28
CN1171115A (zh) 1998-01-21
IL116504A (en) 2001-11-25
PT799238E (pt) 2000-11-30
IL116504A0 (en) 1996-03-31
EP0799238B1 (de) 2000-05-24
US5827842A (en) 1998-10-27
AR002263A1 (es) 1998-03-11
DK0799238T3 (da) 2000-10-09
WO1996020209A2 (de) 1996-07-04
GR3034261T3 (en) 2000-12-29
NO972927L (no) 1997-08-22
LV11954B (lv) 1998-06-20
WO1996020209A3 (de) 1996-09-06
HUP0600457A2 (en) 2006-08-28
PL182642B1 (pl) 2002-02-28
AU692346B2 (en) 1998-06-04
PL320799A1 (en) 1997-10-27
CZ195497A3 (cs) 1998-03-18
NO310198B1 (no) 2001-06-05
ES2151612T3 (es) 2001-01-01
FI972624A (fi) 1997-06-18
CN1109689C (zh) 2003-05-28
SK282281B6 (sk) 2002-01-07
RU2169153C2 (ru) 2001-06-20
SI9520137A (sl) 1998-02-28
NO972927D0 (no) 1997-06-23
CZ292696B6 (cs) 2003-11-12
EE03356B1 (et) 2001-02-15

Similar Documents

Publication Publication Date Title
BG103603A (en) Antigestagene steroids with fluorinated 17 alpha-alkyl chain
LV12618A (en) Use of sulphamate derivatives as steroid sulphatase inhibitors
GEP20012530B (en) Neuroactive Steroids of the Androstane and Pregnane Series
GB2265624B (en) 17-substituted steroids useful in cancer treatment
ZA881962B (en) 19,11beta-bridged steriods,their manufacture and pharmaceutical preparations containing them
TW351714B (en) New vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
TW333536B (en) 14-17-C2-bridged steroids
FI91070B (fi) Parannus androsta-1,4-dieeni-3,17-dionin 6-metyleenijohdannaisten synteesissä
AU2197988A (en) 17-substituted androsta-1,4-dien-3-one derivatives
AU8058391A (en) Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same
FI932873A (fi) D-homo-(16-en)-11b-aryl-4-estrener, foerfarande foer deras framstaellningoch deras anvaendning som laekemedel
GR3023294T3 (en) New 16-methyl substituted steroid derivatives of pregna-1,4-dien-3,20-dione, their preparation, their use in the preparation of 16-methylene substituted steroids and new intermediates therefor
ES8405420A1 (es) Nuevo proceso para la preparacion de esteres de esteroides.
MY113797A (en) 14alpha, alpha 17 -c2-bridged norprogesterone derivatives
DE69126622D1 (de) 2beta,19-methylenamin überbrückte steroide als aromatasehemmer
GR3034563T3 (en) 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them
ATE199159T1 (de) 17-difluormethylen-estratriene
TW345487B (en) Composition for controlling noxious insects and/or mites comprising an ester compound
TW343976B (en) 17-substituted steroids useful in cancer treatment
PL359238A1 (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
NZ333837A (en) estrene steroids for inducing hypothalamic effects

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees